SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-21-028493
Filing Date
2021-07-15
Accepted
2021-07-15 16:21:49
Documents
2
Period of Report
2021-07-14

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1568
2 EX-24 DOCUMENT attachment1.htm EX-24 4047
  Complete submission text file 0000899243-21-028493.txt   7285
Mailing Address 6200 LOOKOUT RD. BOULDER CO 80301
Business Address 6200 LOOKOUT RD. BOULDER CO 80301 720.643.5200
Viridian Therapeutics, Inc.\DE (Issuer) CIK: 0001590750 (see all company filings)

IRS No.: 471187261 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 8071 Services-Medical Laboratories

Mailing Address 79 TW ALEXANDER DRIVE 4501 RESEARCH COMMONS, SUITE 100 RESEARCH TRIANGLE PARK NC 27709
Business Address
Moses Jennifer K. (Reporting) CIK: 0001706667 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36483 | Film No.: 211092908